Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Licensees/CRADA partners sought for antiprogestins

March 7, 1997

Bayer initiates international diabetes prevention project

March 6, 1997

Allelix reports progress in osteoporosis trial

March 6, 1997

Novel post-Amadori inhibitors identified

March 5, 1997

Novo Nordisk to develop compounds discovered by Indian research foundation

March 5, 1997

GelTex receives U.S. patent for CholestaGel

March 5, 1997

Antidiabetic/hypolipidemic agents from Sumitomo Metal

March 5, 1997

Pfizer develops ACAT inhibitors

March 5, 1997

First launch for troglitazone

March 4, 1997

Pramlintide delays gastric emptying in IDDM

March 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...